BeautyHealth reports Q3 net loss of $73.8M, revises FY2023 guidance lower

SkinHealth Systems Inc.

2023-Q3 EPS reported -$0.68 revenue$301,170,000

Net sales $97.4M (+10% YoY) but gross loss of $12.6M vs $61.4M profit a year ago; $63.1M restructuring charge for Syndeo device upgrades.
Net loss $73.8M vs $0.1M loss prior year; adjusted EBITDA $9.1M (9.3% margin) down from $16.3M (18.4% margin).
Revised FY2023 guidance: net sales $385-400M, adjusted EBITDA margin 5-6%; suspends long-term 2025 outlook.
U.S. revenue weaker than expected; APAC and EMEA delivered double-digit growth; total delivery systems sold 2,140 vs 1,860.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SkinHealth Systems Inc. reported third quarter ended September 30, 2023 results: revenue $97.4 million, net income $(73.8). Guidance reaffirmed.

Period: third quarter ended September 30, 2023
Revenue: $97.4 million
Net income: $(73.8)
Guidance: reaffirmed
Result: reported results

Exact text from the filing

revenue and incurs restructuring charges for device upgrades Delivers net sales of $97.4 million driven by double digit growth in APAC and EMEA Long Beach, Calif., November 13, 2023 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2023.

View on SEC.gov

Browse all earnings releases →

SkinHealth Systems Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-038610

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.